Overview

* Dentsply Sirona ( XRAY ) appoints Daniel Scavilla as CEO, effective August 1, 2025

* Company reports preliminary Q2 2025 revenue of $935 mln, beating expectations

* Adjusted EPS for Q2 2025 expected between $0.50 and $0.52

Outlook

* Company reaffirms 2025 outlook from May 8 earnings release

* Dentsply Sirona expects Q2 2025 net sales of $935 mln

* Company anticipates Q2 2025 adjusted EPS between $0.50 and $0.52

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Beat $935 mln $933.10

Prelimin mln (13

ary Analysts

revenue )

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 14 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."

* Wall Street's median 12-month price target for DENTSPLY SIRONA Inc ( XRAY ) is $17.00, about 7.8% above its July 18 closing price of $15.68

* The stock recently traded at 8 times the next 12-month earnings vs. a P/E of 8 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)